Umbilical cord mesenchymal stem cells suppress B-cell proliferation and differentiation

Cellular Immunology

Volumn 274, Issue 1-2, 2012, Pages 46-53

  Che, Nan ^a   Li, Xia ^a   Zhou, Shiliang ^b   Liu, Rui ^a   Shi, Dongyan ^b   Lu, Liwei ^c   Sun, Lingyun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

B cells; B cell proliferation and differentiation; Umbilical cord mesenchymal stem cells

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MESSENGER RNA; PROTEIN KINASE B; SYNAPTOPHYSIN; SYNDECAN 1; TRANSCRIPTION FACTOR PAX5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SPLEEN; UMBILICAL CORD BLOOD; UMBILICAL CORD MESENCHYMAL STEM CELL;

MURINAE;

EID: 84862789093     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.02.004     Document Type: Article

References (49)

1. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
2. Zhang W., Ge W., Li C., You S., Liao L., Han Q., Deng W., Zhao R.C. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev. 2004, 13:263-271.
3. Jiang X.X., Zhang Y., Liu B., Zhang S.X., Wu Y., Yu X.D., Mao N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005, 105:4120-4126.
4. Nauta A.J., Kruisselbrink A.B., Lurvink E., Willemze R., Fibbe W.E. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J. Immunol. 2006, 177:2080-2087.
5. Sotiropoulou P.A., Perez S.A., Gritzapis A.D., Baxevanis C.N., Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 2006, 24:74-85.
6. Spaggiari G.M., Capobianco A., Becchetti S., Mingari M.C., Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006, 107:1484-1490.
7. Yang S.H., Park M.J., Yoon I.H., Kim S.Y., Hong S.H., Shin J.Y., Nam H.Y., Kim Y.H., Kim B., Park C.G. Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. Exp. Mol. Med. 2009, 41:315-324.
8. Corcione A., Benvenuto F., Ferretti E., Giunti D., Cappiello V., Cazzanti F., Risso M., Gualandi F., Mancardi G.L., Pistoia V. Human mesenchymal stem cells modulate B cell functions. Blood 2006, 107:367-372.
9. Rafei M., Hsieh J., Fortier S., Li M.Y., Yuan S., Birman E., Forner K., Boivin M.N., Doody K., Tremblay M., Annabi B., Galipeau J. Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. Blood 2008, 112:4991-4998.
10. Comoli P., Ginevri F., Maccario R., Avanzini M.A., Marconi M., Groff A., Cometa A., Cioni M., Porretti L., Barberi W., Frassoni F., Locatelli F. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. Nephrol. Dial. Transplant. 2008, 23:1196-1202.
11. Tabera S., Simón J.A.P., Campelo M.D., Abarca L.I.S., Blanco B., López A., Benito A., Ocio E., Guijo F.M.S., Cañizo C., Miguel J.F.S. The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. Haematologica 2008, 93:1301-1309.
12. Asaria S., Itakuraa S., Ferreria K., Liub C., Kurodaa Y., Kandeela F., Mullen Y. Mesenchymal stem cells suppress B-cell terminal differentiation. Exp. Hematol. 2009, 37:604-615.
13. Schena F., Gambini C., Gregorio A., Mosconi M., Reverberi D., Gattorno M., Casazza S., Uccelli A., Moretta L., Martini A., Traggiai E. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of Systemic Lupus Erythematosus. Arthritis. Rheum. 2010, 62:2776-2786.
14. Stenderup K., Justesen J., Clausen C., Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003, 33:919-926.
15. Nishida S., Endo N., Yamagiwa H., Tanizawa T., Takahashi H.E. Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J. Bone. Miner. Metab. 1999, 17:171-177.
16. Mueller S.M., Glowacki J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J. Cell. Biochem. 2001, 82:583-590.
17. Zhang H., Fazel S., Tian H., Mickle D.A., Weisel R.D., Fujii T., Li R.K. Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H2089-H2096.
18. Friedenstein A.J., Petrakova K.V., Kurolesova A.I., Frolova G.P. Heterotopic of bone marrow: Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968, 6:230-247.
19. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Gonzalez X.R.O., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada D.A., Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
20. Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007, 110:3499-3506.
21. Weiss M.L., Medicetty S., Bledsoe A.R., Rachakatla R.S., Choi M., Merchav S., Luo Y., Rao M.S., Velagaleti G., Troyer D. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006, 24:781-792.
22. Medicetty S., Bledsoe A.R., Fahrenholtz C.B., Troyer D., Weiss M.L. Transplantation of pig stem cells into rat brain: proliferation during the first 8 weeks. Exp. Neurol. 2004, 190:32-41.
23. Lu L.L., Liu Y.J., Yang S.G., Zhao Q.J., Wang X., Gong W., Han Z.B., Xu Z.S., Lu Y.X., Liu D., Chen Z.Z., Han Z.C. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesissupportive function and other potentials. Haematologica 2006, 91:1017-1026.
24. Li G., Zhang X.A., Wang H., Wang X., Meng C.L., Chan C.Y., Yew D.T.W., Tsang K.S., Li K., Tsai S.N., Ngai S.M., Han Z.C., Lin M.C.M., He M.L., Kung H.F. Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: implication in the migration. Proteomics 2009, 9:20-30.
25. H. Cheng, L. Qiu, J. Ma, H. Zhang, M. Cheng, W. Li, X. Zhao, K. Liu, Replicative senescence of human bone marrow and umbilical cord derived mesenchymal stem cells and their differentiation to adipocytes and osteoblasts, Mol. Biol. Rep. Epub ahead of print (2010).
26. Chen M.Y., Lie P.C., Li Z.L., Wei X. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Exp. Hematol. 2009, 37:629-640.
27. Chen K., Wang D., Du W.T., Han Z.B., Ren H., Chi Y., Yang S.G., Zhu D., Bayard F., Han Z.C. Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Clin. Immunol. 2010, 135:448-458.
28. Cutler A.J., Limbani V., Girdlestone J., Navarrete C.V. Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation. J. Immunol. 2010, 185:6617-6623.
29. Liu Y., Mu R., Wang S., Long L., Liu X., Li R., Sun J., Guo J., Zhang X., Guo J., Yu P., Li C., Liu X., Huang Z., Wang D., Li H., Gu Z., Liu B., Li Z. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis. Res. Ther. 2010, 12:R210.
30. Sun L., Wang D., Liang J., Zhang H., Feng X., Wang H., Hua B., Liu B., Ye S., Hu X., Xu W., Zeng X., Hou Y., Gilkeson G.S., Silver R.M., Lu L., Shi S. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis. Rheum. 2010, 62:2467-2475.
31. Traggiai E., Volpi S., Schena F., Gattorno M., Ferlito F., Moretta L., Martini A. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem cells 2008, 26:562-569.
32. Rasmusson I., Blanc K.L., Sundberg B., Ringdén O. Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand. J. Immunol. 2007, 65:336-343.
33. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., Giunti D., Ceravolo A., Cazzanti F., Frassoni F., Mancardi G., Uccelli A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy. Blood 2005, 106:1755-1761.
34. Lin Y., Wong K., Calame K. Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science 1997, 276:596-599.
35. Reimold A.M., Iwakoshi N.N., Manis J., Vallabhajosyula P., Tsuda E.S., Gravallese E.M., Friend D., Grusby M.J., Alt F., Glimcher L.H. Plasma cell differentiation requires the transcription factor XBP-1. Nature 2001, 412:300-307.
36. Horcher M., Souabni A., Busslinger M. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity 2001, 14:779-790.
37. Dent A.L., Shaffer A.L., Yu X., Allman D., Staudt L.M. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 1997, 276:589-592.
38. Nera K.P., Kohonen P., Narvi E., Peippo A., Mustonen L., Terho P., Koskela K., Buerstedde J.M., Lassila O. Loss of Pax5 promotes plasma cell differentiation. Immunity 2006, 24:283-293.
39. Delogu A., Schebesta A., Sun Q., Aschenbrenner K., Perlot T., Busslinger M. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity 2006, 24:269-281.
40. Ye B.H., Cattoretti G., Shen Q., Zhang J., Hawe N., Waard R., Leung C., Shirazi M.N., Orazi A., Chaganti R.S., Rothman P., Stall A.M., Pandolfi P.P., Favera R.D. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat. Genet. 1997, 16:161-170.
41. Fukuda T., Yoshida T., Okada S., Hatano M., Miki T., Ishibashi K., Okabe S., Koseki H., Hirosawa S., Taniguchi M., Miyasaka N., Tokuhisa T. Disruption of the Bcl6 gene results in an impaired germinal center formation. J. Exp. Med. 1997, 186:439-448.
42. Shelef M.S., Calame K. Regulation of plasma-cell development. Nat. Rev. Immunol. 2005, 5:230-242.
43. Hess P., Pihan G., Sawyers C.L., Flavell R.A., Davis R.J. Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts. Nat. Genet. 2002, 32:201-205.
44. Vasanwala F.H., Kusam S., Toney L.M., Dent A.L. Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. J. Immunol. 2002, 169:1922-1929.
45. Ohkubo Y., Arima M., Arguni E., Okada S., Yamashita K., Asari S., Obata S., Sakamoto A., Hatano M., Wang J.O., Ebara M., Saisho H., Tokuhisa T. A role for c-fos/activator protein 1 in B lymphocyte terminal differentiation. J. Immunol. 2005, 174:7703-7710.
46. Tunyaplin C., Shaffer A.L., Angelin-Duclos C.D., Yu X., Staudt L.M., Calame K.L. Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J. Immunol. 2004, 173:1158-1165.
47. Aiba Y., Yamazaki T., Okada T., Gotoh K., Sanjo H., Ogata M., Kurosaki T. BANK negatively regulates Akt activation and subsequent B cell responses. Immunity 2006, 24:259-268.
48. Kim J., Yang H.Y., Jang Y.S. A G-protein-associated ERK pathway is involved in LPS-induced proliferation and a PTK-associated p38 MAPK pathway is involved in LPS-induced differentiation in resting mB cells. Mol. Immunol. 2006, 43:1232-1242.
49. Ertesvag A., Aasheim H.C., Naderi S., Blomhoff H.K. Vitamin A potentiates CpG-mediated memory B-cell proliferation and differentiation: involvement of early activation of p38 MAPK. Blood 2007, 109:3865-3872.